CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: a personalized molecular surgical therapy. EMBO molecular medicine Tang, H., Shrager, J. B. 2016; 8 (2): 83–85

View details for PubMedID 26747090